These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28086747)

  • 1. MicroRNA based Pan-Cancer Diagnosis and Treatment Recommendation.
    Cheerla N; Gevaert O
    BMC Bioinformatics; 2017 Jan; 18(1):32. PubMed ID: 28086747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tree-based machine learning algorithms identified minimal set of miRNA biomarkers for breast cancer diagnosis and molecular subtyping.
    Sherafatian M
    Gene; 2018 Nov; 677():111-118. PubMed ID: 30055304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automatic discovery of 100-miRNA signature for cancer classification using ensemble feature selection.
    Lopez-Rincon A; Martinez-Archundia M; Martinez-Ruiz GU; Schoenhuth A; Tonda A
    BMC Bioinformatics; 2019 Sep; 20(1):480. PubMed ID: 31533612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer survival classification using integrated data sets and intermediate information.
    Kim S; Park T; Kon M
    Artif Intell Med; 2014 Sep; 62(1):23-31. PubMed ID: 24997860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA arm switching identifies novel tumour biomarkers.
    Chen L; Sun H; Wang C; Yang Y; Zhang M; Wong G
    EBioMedicine; 2018 Dec; 38():37-46. PubMed ID: 30425004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Type Prediction and Classification Based on RNA-sequencing Data.
    Hsu YH; Si D
    Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():5374-5377. PubMed ID: 30441551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study.
    Bagnoli M; Canevari S; Califano D; Losito S; Maio MD; Raspagliesi F; Carcangiu ML; Toffoli G; Cecchin E; Sorio R; Canzonieri V; Russo D; Scognamiglio G; Chiappetta G; Baldassarre G; Lorusso D; Scambia G; Zannoni GF; Savarese A; Carosi M; Scollo P; Breda E; Murgia V; Perrone F; Pignata S; De Cecco L; Mezzanzanica D;
    Lancet Oncol; 2016 Aug; 17(8):1137-1146. PubMed ID: 27402147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-cancer classification by regularized multi-task learning.
    Hossain SMM; Khatun L; Ray S; Mukhopadhyay A
    Sci Rep; 2021 Dec; 11(1):24252. PubMed ID: 34930937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge about the presence or absence of miRNA isoforms (isomiRs) can successfully discriminate amongst 32 TCGA cancer types.
    Telonis AG; Magee R; Loher P; Chervoneva I; Londin E; Rigoutsos I
    Nucleic Acids Res; 2017 Apr; 45(6):2973-2985. PubMed ID: 28206648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A microRNA expression profile for vascular invasion can predict overall survival in hepatocellular carcinoma.
    Lin Z; Cai YJ; Chen RC; Chen BC; Zhao L; Xu SH; Wang XD; Song M; Wu JM; Wang YQ; Zhou MT; Shi KQ
    Clin Chim Acta; 2017 Jun; 469():171-179. PubMed ID: 28365450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy.
    Cheng G
    Adv Drug Deliv Rev; 2015 Jan; 81():75-93. PubMed ID: 25220354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fast and accurate microRNA search using CNN.
    Tang X; Sun Y
    BMC Bioinformatics; 2019 Dec; 20(Suppl 23):646. PubMed ID: 31881831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constructing diagnostic signature of serum microRNAs using machine learning for early pan-cancer detection.
    Xu Y; Liao W; Chen H; Pan M
    Discov Oncol; 2024 Jul; 15(1):263. PubMed ID: 38965104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixture classification model based on clinical markers for breast cancer prognosis.
    Zeng T; Liu J
    Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A semi-supervised machine learning framework for microRNA classification.
    Sheikh Hassani M; Green JR
    Hum Genomics; 2019 Oct; 13(Suppl 1):43. PubMed ID: 31639051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating microRNA-based screening tool for breast cancer.
    Frères P; Wenric S; Boukerroucha M; Fasquelle C; Thiry J; Bovy N; Struman I; Geurts P; Collignon J; Schroeder H; Kridelka F; Lifrange E; Jossa V; Bours V; Josse C; Jerusalem G
    Oncotarget; 2016 Feb; 7(5):5416-28. PubMed ID: 26734993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
    Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
    Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The feature selection bias problem in relation to high-dimensional gene data.
    Krawczuk J; Łukaszuk T
    Artif Intell Med; 2016 Jan; 66():63-71. PubMed ID: 26674595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [MicroRNA target predicition based on SVM and the optimized feature set].
    Wang B; Qi X; Wang C; Liu W; Si Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Dec; 30(6):1213-8. PubMed ID: 24645599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Limitations of Existing Approaches in Improving MicroRNA Target Prediction Accuracy.
    Loganantharaj R; Randall TA
    Methods Mol Biol; 2017; 1617():133-158. PubMed ID: 28540682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.